Sodium-glucose cotransporter 2, or SGLT2, inhibitors and glucagon-like peptide-1 receptor agonists lowered the risk for COPD exacerbation in adults with the disease and type 2 diabetes, researchers ...
Amy Schumer is getting candid about her unpleasant experience on the weight loss drug Ozempic. The comedian and actress, 43, ...
4h
HealthDay on MSNGLP-1 Meds Can Work Wonders for Kidney HealthOzempic, Wegovy, Saxenda, Trulicity: These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks ...
A study finds GLP-1 weight-loss drugs may pose vision risks, revealing an unexpected medical irony. A paradoxical insight: ...
Although reports of vision problems with weight loss drugs are still rare, researchers say there is cause for concern because of how widespread the medications are becoming. A 2024 study found that 12 ...
Doctors have begun noticing a trend: they all seem to get full before finishing dinner, and it's likely thanks to drugs like ...
Reports link GLP-1 medications like Ozempic and Mounjaro to vision loss, prompting concerns over their safety.
Zero Doubt Club, a Northeast Ohio-based wellness center, has introduced a GLP-1 weight-loss program that combines medical ...
The increase in overall case volume was driven by growth in North America, Asia Pacific and Latin America, as increases in sparkling soft drinks, water, sports, coffee and tea offset declines in juice ...
Learn about the financial strain caused by the skyrocketing demand and costs of GLP-1 drugs, and how health plans and providers are struggling to balance it.
These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results